Skip to main content
Top
Published in: Virchows Archiv 2/2017

01-08-2017 | Invited Review for the Annual Review Issue

The ins and outs of molecular pathology reporting

Authors: Véronique Tack, Kelly Dufraing, Zandra C. Deans, Han J. van Krieken, Elisabeth M. C. Dequeker

Published in: Virchows Archiv | Issue 2/2017

Login to get access

Abstract

The raid evolution in molecular pathology resulting in an increasing complexity requires careful reporting. The need for standardisation is clearer than ever. While synoptic reporting was first used for reporting hereditary genetic diseases, it is becoming more frequent in pathology, especially molecular pathology reports too. The narrative approach is no longer feasible with the growing amount of essential data present on the report, although narrative components are still necessary for interpretation in molecular pathology. On the way towards standardisation of reports, guidelines can be a helpful tool. There are several guidelines that focus on reporting in the field of hereditary diseases, but it is not always feasible to extrapolate these to the reporting of somatic variants in molecular pathology. The rise of multi-gene testing causes challenges for the laboratories. In order to provide a continuous optimisation of the laboratory testing process, including reporting, external quality assessment is essential and has already proven to improve the quality of reports. In general, a clear and concise report for molecular pathology can be created by including elements deemed important by different guidelines, adapting the report to the process flows of the laboratory and integrating the report with the laboratory information management system and the patient record.
Literature
3.
go back to reference Pantanowitz L, Tuthill JM, Balis U (2012) Pathology informatics: theory & practice. American Society of Clinical Pathologists Pantanowitz L, Tuthill JM, Balis U (2012) Pathology informatics: theory & practice. American Society of Clinical Pathologists
4.
go back to reference Compton CC (1999) Pathology report in colon cancer: what is prognostically important? Dig Dis 17(2):67–79 doi: 16908CrossRefPubMed Compton CC (1999) Pathology report in colon cancer: what is prognostically important? Dig Dis 17(2):67–79 doi: 16908CrossRefPubMed
6.
go back to reference Cree IA, Deans Z, Ligtenberg MJL, Normanno N, Edsjö A, Rouleau E, Solé F, Thunnissen E, Timens W, Schuuring E, Dequeker E, Murray S, Dietel M, Groenen P, Van Krieken JH, Pathology ftESoPTFoQAiM, Pathologists tRCo (2014) Guidance for laboratories performing molecular pathology for cancer patients. J Clin Pathol 67(11):923–931. doi:10.1136/jclinpath-2014-202404 CrossRefPubMedPubMedCentral Cree IA, Deans Z, Ligtenberg MJL, Normanno N, Edsjö A, Rouleau E, Solé F, Thunnissen E, Timens W, Schuuring E, Dequeker E, Murray S, Dietel M, Groenen P, Van Krieken JH, Pathology ftESoPTFoQAiM, Pathologists tRCo (2014) Guidance for laboratories performing molecular pathology for cancer patients. J Clin Pathol 67(11):923–931. doi:10.​1136/​jclinpath-2014-202404 CrossRefPubMedPubMedCentral
7.
go back to reference Breastcancer.org (2016) Your guide to the breast cancer pathology report. Breastcancer.org. Accessed 6 Jan 2017 Breastcancer.org (2016) Your guide to the breast cancer pathology report. Breastcancer.org. Accessed 6 Jan 2017
9.
go back to reference Srigley JR, McGowan T, Maclean A, Raby M, Ross J, Kramer S, Sawka C (2009) Standardized synoptic cancer pathology reporting: a population-based approach. J Surg Oncol 99(8):517–524. doi:10.1002/jso.21282 CrossRefPubMed Srigley JR, McGowan T, Maclean A, Raby M, Ross J, Kramer S, Sawka C (2009) Standardized synoptic cancer pathology reporting: a population-based approach. J Surg Oncol 99(8):517–524. doi:10.​1002/​jso.​21282 CrossRefPubMed
13.
go back to reference Casati B, Bjugn R (2012) Structured electronic template for histopathology reporting on colorectal carcinoma resections: five-year follow-up shows sustainable long-term quality improvement. Arch Pathol Lab Med 136(6):652–656. doi:10.5858/arpa.2011-0370-OA CrossRefPubMed Casati B, Bjugn R (2012) Structured electronic template for histopathology reporting on colorectal carcinoma resections: five-year follow-up shows sustainable long-term quality improvement. Arch Pathol Lab Med 136(6):652–656. doi:10.​5858/​arpa.​2011-0370-OA CrossRefPubMed
14.
go back to reference Gill AJ, Johns AL, Eckstein R, Samra JS, Kaufman A, Chang DK, Merrett ND, Cosman PH, Smith RC, Biankin AV, Kench JG (2009) Synoptic reporting improves histopathological assessment of pancreatic resection specimens. Pathology 41(2):161–167CrossRefPubMed Gill AJ, Johns AL, Eckstein R, Samra JS, Kaufman A, Chang DK, Merrett ND, Cosman PH, Smith RC, Biankin AV, Kench JG (2009) Synoptic reporting improves histopathological assessment of pancreatic resection specimens. Pathology 41(2):161–167CrossRefPubMed
17.
go back to reference Lankshear S, Srigley J, McGowan T, Yurcan M, Sawka C (2013) Standardized synoptic cancer pathology reports—so what and who cares? A population-based satisfaction survey of 970 pathologists, surgeons, and oncologists. Arch Pathol Lab Med 137(11):1599–1602. doi:10.5858/arpa.2012-0656-OA CrossRefPubMed Lankshear S, Srigley J, McGowan T, Yurcan M, Sawka C (2013) Standardized synoptic cancer pathology reports—so what and who cares? A population-based satisfaction survey of 970 pathologists, surgeons, and oncologists. Arch Pathol Lab Med 137(11):1599–1602. doi:10.​5858/​arpa.​2012-0656-OA CrossRefPubMed
19.
go back to reference Lubin IM, McGovern MM, Gibson Z, Gross SJ, Lyon E, Pagon RA, Pratt VM, Rashid J, Shaw C, Stoddard L, Trotter TL, Williams MS, Amos Wilson J, Pass K (2009) Clinician perspectives about molecular genetic testing for heritable conditions and development of a clinician-friendly laboratory report. J Mol Diagn 11(2):162–171. doi:10.2353/jmoldx.2009.080130 CrossRefPubMedPubMedCentral Lubin IM, McGovern MM, Gibson Z, Gross SJ, Lyon E, Pagon RA, Pratt VM, Rashid J, Shaw C, Stoddard L, Trotter TL, Williams MS, Amos Wilson J, Pass K (2009) Clinician perspectives about molecular genetic testing for heritable conditions and development of a clinician-friendly laboratory report. J Mol Diagn 11(2):162–171. doi:10.​2353/​jmoldx.​2009.​080130 CrossRefPubMedPubMedCentral
23.
go back to reference Schwaederle M, Parker BA, Schwab RB, Fanta PT, Boles SG, Daniels GA, Bazhenova LA, Subramanian R, Coutinho AC, Ojeda-Fournier H, Datnow B, Webster NJ, Lippman SM, Kurzrock R (2014) Molecular tumor board: the University of California-San Diego Moores Cancer Center experience. Oncologist 19(6):631–636. doi:10.1634/theoncologist.2013-0405 CrossRefPubMedPubMedCentral Schwaederle M, Parker BA, Schwab RB, Fanta PT, Boles SG, Daniels GA, Bazhenova LA, Subramanian R, Coutinho AC, Ojeda-Fournier H, Datnow B, Webster NJ, Lippman SM, Kurzrock R (2014) Molecular tumor board: the University of California-San Diego Moores Cancer Center experience. Oncologist 19(6):631–636. doi:10.​1634/​theoncologist.​2013-0405 CrossRefPubMedPubMedCentral
24.
go back to reference Jalil R, Ahmed M, Green JS, Sevdalis N (2013) Factors that can make an impact on decision-making and decision implementation in cancer multidisciplinary teams: an interview study of the provider perspective. Int J Surg 11(5):389–394. doi:10.1016/j.ijsu.2013.02.026 CrossRefPubMed Jalil R, Ahmed M, Green JS, Sevdalis N (2013) Factors that can make an impact on decision-making and decision implementation in cancer multidisciplinary teams: an interview study of the provider perspective. Int J Surg 11(5):389–394. doi:10.​1016/​j.​ijsu.​2013.​02.​026 CrossRefPubMed
25.
go back to reference Gulley ML, Braziel RM, Halling KC, Hsi ED, Kant JA, Nikiforova MN, Nowak JA, Ogino S, Oliveira A, Polesky HF, Silverman L, Tubbs RR, Van Deerlin VM, Vance GH, Versalovic J (2007) Clinical laboratory reports in molecular pathology. Arch Pathol Lab Med 131(6):852–863PubMed Gulley ML, Braziel RM, Halling KC, Hsi ED, Kant JA, Nikiforova MN, Nowak JA, Ogino S, Oliveira A, Polesky HF, Silverman L, Tubbs RR, Van Deerlin VM, Vance GH, Versalovic J (2007) Clinical laboratory reports in molecular pathology. Arch Pathol Lab Med 131(6):852–863PubMed
26.
go back to reference Matthijs G, Souche E, Alders M, Corveleyn A, Eck S, Feenstra I, Race V, Sistermans E, Sturm M, Weiss M, Yntema H, Bakker E, Scheffer H, Bauer P (2016) Guidelines for diagnostic next-generation sequencing. Eur J Hum Genet 24(1):2–5. doi:10.1038/ejhg.2015.226 CrossRefPubMed Matthijs G, Souche E, Alders M, Corveleyn A, Eck S, Feenstra I, Race V, Sistermans E, Sturm M, Weiss M, Yntema H, Bakker E, Scheffer H, Bauer P (2016) Guidelines for diagnostic next-generation sequencing. Eur J Hum Genet 24(1):2–5. doi:10.​1038/​ejhg.​2015.​226 CrossRefPubMed
28.
go back to reference Organisation for Economic Co-operation and Development (OECD) (2005) Quality assurance and proficiency testing for molecular genetic testing: summary report of a survey of 18 OECD Member Countries Organisation for Economic Co-operation and Development (OECD) (2005) Quality assurance and proficiency testing for molecular genetic testing: summary report of a survey of 18 OECD Member Countries
29.
go back to reference van Krieken JH, Normanno N, Blackhall F, Boone E, Botti G, Carneiro F, Celik I, Ciardiello F, Cree IA, Deans ZC, Edsjo A, Groenen PJ, Kamarainen O, Kreipe HH, Ligtenberg MJ, Marchetti A, Murray S, Opdam FJ, Patterson SD, Patton S, Pinto C, Rouleau E, Schuuring E, Sterck S, Taron M, Tejpar S, Timens W, Thunnissen E, van de Ven PM, Siebers AG, Dequeker E (2013) Guideline on the requirements of external quality assessment programs in molecular pathology. Virchows Arch 462(1):27–37. doi:10.1007/s00428-012-1354-4 CrossRefPubMed van Krieken JH, Normanno N, Blackhall F, Boone E, Botti G, Carneiro F, Celik I, Ciardiello F, Cree IA, Deans ZC, Edsjo A, Groenen PJ, Kamarainen O, Kreipe HH, Ligtenberg MJ, Marchetti A, Murray S, Opdam FJ, Patterson SD, Patton S, Pinto C, Rouleau E, Schuuring E, Sterck S, Taron M, Tejpar S, Timens W, Thunnissen E, van de Ven PM, Siebers AG, Dequeker E (2013) Guideline on the requirements of external quality assessment programs in molecular pathology. Virchows Arch 462(1):27–37. doi:10.​1007/​s00428-012-1354-4 CrossRefPubMed
30.
go back to reference International Organization for Standardization (2012) ISO 15189:2012 Medical laboratories - Particular requirements for quality and competence. ISO Geneva, Switzerland International Organization for Standardization (2012) ISO 15189:2012 Medical laboratories - Particular requirements for quality and competence. ISO Geneva, Switzerland
31.
go back to reference Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424. doi:10.1038/gim.2015.30 CrossRefPubMedPubMedCentral Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424. doi:10.​1038/​gim.​2015.​30 CrossRefPubMedPubMedCentral
33.
go back to reference Organisation for Economic C-o, Development (2007) OECD guidelines for quality assurance in molecular genetic testing. OECD Paris, France Organisation for Economic C-o, Development (2007) OECD guidelines for quality assurance in molecular genetic testing. OECD Paris, France
37.
go back to reference Tack V, Deans ZC, Wolstenholme N, Patton S, Dequeker EM (2016) What's in a name? A coordinated approach toward the correct use of a uniform nomenclature to improve patient reports and databases. Hum Mutat 37(6):570–575. doi:10.1002/humu.22975 CrossRefPubMed Tack V, Deans ZC, Wolstenholme N, Patton S, Dequeker EM (2016) What's in a name? A coordinated approach toward the correct use of a uniform nomenclature to improve patient reports and databases. Hum Mutat 37(6):570–575. doi:10.​1002/​humu.​22975 CrossRefPubMed
39.
go back to reference Snyder SR, Favoretto AM, Derzon JH, Christenson RH, Kahn SE, Shaw CS, Baetz RA, Mass D, Fantz CR, Raab SS, Tanasijevic MJ, Liebow EB (2012) Effectiveness of barcoding for reducing patient specimen and laboratory testing identification errors: a laboratory medicine best practices systematic review and meta-analysis. Clin Biochem 45(13–14):988–998. doi:10.1016/j.clinbiochem.2012.06.019 CrossRefPubMedPubMedCentral Snyder SR, Favoretto AM, Derzon JH, Christenson RH, Kahn SE, Shaw CS, Baetz RA, Mass D, Fantz CR, Raab SS, Tanasijevic MJ, Liebow EB (2012) Effectiveness of barcoding for reducing patient specimen and laboratory testing identification errors: a laboratory medicine best practices systematic review and meta-analysis. Clin Biochem 45(13–14):988–998. doi:10.​1016/​j.​clinbiochem.​2012.​06.​019 CrossRefPubMedPubMedCentral
41.
go back to reference Dorschner MO, Amendola LM, Shirts BH, Kiedrowski L, Salama J, Gordon AS, Fullerton SM, Tarczy-Hornoch P, Byers PH, Jarvik GP (2014) Refining the structure and content of clinical genomic reports. Am J Med Genet C Semin Med Genet 166c(1):85–92. doi:10.1002/ajmg.c.31395 CrossRefPubMed Dorschner MO, Amendola LM, Shirts BH, Kiedrowski L, Salama J, Gordon AS, Fullerton SM, Tarczy-Hornoch P, Byers PH, Jarvik GP (2014) Refining the structure and content of clinical genomic reports. Am J Med Genet C Semin Med Genet 166c(1):85–92. doi:10.​1002/​ajmg.​c.​31395 CrossRefPubMed
42.
go back to reference den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, Roux AF, Smith T, Antonarakis SE, Taschner PE (2016) HGVS recommendations for the description of sequence variants: 2016 update. Hum Mut 37(6):564–569. doi:10.1002/humu.22981 CrossRef den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, Roux AF, Smith T, Antonarakis SE, Taschner PE (2016) HGVS recommendations for the description of sequence variants: 2016 update. Hum Mut 37(6):564–569. doi:10.​1002/​humu.​22981 CrossRef
43.
go back to reference Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, Tsimberidou AM, Vnencak-Jones CL, Wolff DJ, Younes A, Nikiforova MN (2017) Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn 19(1):4–23. doi:10.1016/j.jmoldx.2016.10.002 CrossRefPubMed Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, Tsimberidou AM, Vnencak-Jones CL, Wolff DJ, Younes A, Nikiforova MN (2017) Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn 19(1):4–23. doi:10.​1016/​j.​jmoldx.​2016.​10.​002 CrossRefPubMed
45.
go back to reference van El CG, Cornel MC, Borry P, Hastings RJ, Fellmann F, Hodgson SV, Howard HC, Cambon-Thomsen A, Knoppers BM, Meijers-Heijboer H, Scheffer H, Tranebjaerg L, Dondorp W, de Wert GM (2013) Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics. Eur J Hum Genet 21(6):580–584. doi:10.1038/ejhg.2013.46 PubMedPubMedCentral van El CG, Cornel MC, Borry P, Hastings RJ, Fellmann F, Hodgson SV, Howard HC, Cambon-Thomsen A, Knoppers BM, Meijers-Heijboer H, Scheffer H, Tranebjaerg L, Dondorp W, de Wert GM (2013) Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics. Eur J Hum Genet 21(6):580–584. doi:10.​1038/​ejhg.​2013.​46 PubMedPubMedCentral
46.
go back to reference Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, Rehm HL, Watson MS, Williams MS, Biesecker LG (2013) ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 15(7):565–574. doi:10.1038/gim.2013.73 CrossRefPubMedPubMedCentral Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, Rehm HL, Watson MS, Williams MS, Biesecker LG (2013) ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 15(7):565–574. doi:10.​1038/​gim.​2013.​73 CrossRefPubMedPubMedCentral
47.
go back to reference Jones S, Anagnostou V, Lytle K, Parpart-Li S, Nesselbush M, Riley DR, Shukla M, Chesnick B, Kadan M, Papp E, Galens KG, Murphy D, Zhang T, Kann L, Sausen M, Angiuoli SV, Diaz LA, Velculescu VE (2015) Personalized genomic analyses for cancer mutation discovery and interpretation. Sci Transl Med 7(283):283ra253–283ra253. doi:10.1126/scitranslmed.aaa7161 CrossRef Jones S, Anagnostou V, Lytle K, Parpart-Li S, Nesselbush M, Riley DR, Shukla M, Chesnick B, Kadan M, Papp E, Galens KG, Murphy D, Zhang T, Kann L, Sausen M, Angiuoli SV, Diaz LA, Velculescu VE (2015) Personalized genomic analyses for cancer mutation discovery and interpretation. Sci Transl Med 7(283):283ra253–283ra253. doi:10.​1126/​scitranslmed.​aaa7161 CrossRef
48.
go back to reference Raymond VM, Gray SW, Roychowdhury S, Joffe S, Chinnaiyan AM, Parsons DW, Plon SE (2016) Germline findings in tumor-only sequencing: points to consider for clinicians and laboratories. J Natl Cancer Inst 108(4). doi:10.1093/jnci/djv351 Raymond VM, Gray SW, Roychowdhury S, Joffe S, Chinnaiyan AM, Parsons DW, Plon SE (2016) Germline findings in tumor-only sequencing: points to consider for clinicians and laboratories. J Natl Cancer Inst 108(4). doi:10.​1093/​jnci/​djv351
52.
go back to reference Paszko C, Pugsley C (2000) Considerations in selecting a laboratory information management system (LIMS). Am Lab 32(18):38–42 Paszko C, Pugsley C (2000) Considerations in selecting a laboratory information management system (LIMS). Am Lab 32(18):38–42
54.
go back to reference Oral B, Cullen RM, Diaz DL, Hod EA, Kratz A (2015) Downtime procedures for the 21st century: using a fully integrated health record for uninterrupted electronic reporting of laboratory results during laboratory information system downtimes. Am J Clin Pathol 143(1):100–104. doi:10.1309/ajcpm0o7mnvgcevt CrossRefPubMed Oral B, Cullen RM, Diaz DL, Hod EA, Kratz A (2015) Downtime procedures for the 21st century: using a fully integrated health record for uninterrupted electronic reporting of laboratory results during laboratory information system downtimes. Am J Clin Pathol 143(1):100–104. doi:10.​1309/​ajcpm0o7mnvgcevt​ CrossRefPubMed
58.
go back to reference Deans ZC, Bilbe N, O'Sullivan B, Lazarou LP, de Castro DG, Parry S, Dodson A, Taniere P, Clark C, Butler R (2013) Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment. J Clin Pathol 66(4):319–325. doi:10.1136/jclinpath-2012-201227 CrossRefPubMed Deans ZC, Bilbe N, O'Sullivan B, Lazarou LP, de Castro DG, Parry S, Dodson A, Taniere P, Clark C, Butler R (2013) Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment. J Clin Pathol 66(4):319–325. doi:10.​1136/​jclinpath-2012-201227 CrossRefPubMed
59.
go back to reference Patton S, Normanno N, Blackhall F, Murray S, Kerr KM, Dietel M, Filipits M, Benlloch S, Popat S, Stahel R, Thunnissen E (2014) Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing. Br J Cancer 111(2):413–420. doi:10.1038/bjc.2014.353 CrossRefPubMedPubMedCentral Patton S, Normanno N, Blackhall F, Murray S, Kerr KM, Dietel M, Filipits M, Benlloch S, Popat S, Stahel R, Thunnissen E (2014) Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing. Br J Cancer 111(2):413–420. doi:10.​1038/​bjc.​2014.​353 CrossRefPubMedPubMedCentral
60.
go back to reference Tembuyser L, Ligtenberg MJ, Normanno N, Delen S, van Krieken JH, Dequeker EM (2014) Higher quality of molecular testing, an unfulfilled priority: results from external quality assessment for KRAS mutation testing in colorectal cancer. J Mol Diagn 16(3):371–377. doi:10.1016/j.jmoldx.2014.01.003 CrossRefPubMed Tembuyser L, Ligtenberg MJ, Normanno N, Delen S, van Krieken JH, Dequeker EM (2014) Higher quality of molecular testing, an unfulfilled priority: results from external quality assessment for KRAS mutation testing in colorectal cancer. J Mol Diagn 16(3):371–377. doi:10.​1016/​j.​jmoldx.​2014.​01.​003 CrossRefPubMed
61.
go back to reference Tembuyser L, Tack V, Zwaenepoel K, Pauwels P, Miller K, Bubendorf L, Kerr K, Schuuring E, Thunnissen E, Dequeker EM (2014) The relevance of external quality assessment for molecular testing for ALK positive non-small cell lung cancer: results from two pilot rounds show room for optimization. PLoS One 9(11):e112159. doi:10.1371/journal.pone.0112159 CrossRefPubMedPubMedCentral Tembuyser L, Tack V, Zwaenepoel K, Pauwels P, Miller K, Bubendorf L, Kerr K, Schuuring E, Thunnissen E, Dequeker EM (2014) The relevance of external quality assessment for molecular testing for ALK positive non-small cell lung cancer: results from two pilot rounds show room for optimization. PLoS One 9(11):e112159. doi:10.​1371/​journal.​pone.​0112159 CrossRefPubMedPubMedCentral
64.
go back to reference Deans ZC, Fairley JA, den Dunnen JT, Clark C (2016) HGVS nomenclature in practice: an example from the United Kingdom National External Quality Assessment Scheme. Hum Mutat 37(6):576–578. doi:10.1002/humu.22978 CrossRefPubMed Deans ZC, Fairley JA, den Dunnen JT, Clark C (2016) HGVS nomenclature in practice: an example from the United Kingdom National External Quality Assessment Scheme. Hum Mutat 37(6):576–578. doi:10.​1002/​humu.​22978 CrossRefPubMed
66.
67.
go back to reference Deans ZC, Tull J, Beighton G, Abbs S, Robinson DO, Butler R (2011) Molecular genetics external quality assessment pilot scheme for KRAS analysis in metastatic colorectal cancer. Genet Test Mol Biomarkers 15(11):777–783. doi:10.1089/gtmb.2010.0239 CrossRefPubMed Deans ZC, Tull J, Beighton G, Abbs S, Robinson DO, Butler R (2011) Molecular genetics external quality assessment pilot scheme for KRAS analysis in metastatic colorectal cancer. Genet Test Mol Biomarkers 15(11):777–783. doi:10.​1089/​gtmb.​2010.​0239 CrossRefPubMed
Metadata
Title
The ins and outs of molecular pathology reporting
Authors
Véronique Tack
Kelly Dufraing
Zandra C. Deans
Han J. van Krieken
Elisabeth M. C. Dequeker
Publication date
01-08-2017
Publisher
Springer Berlin Heidelberg
Published in
Virchows Archiv / Issue 2/2017
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-017-2108-0

Other articles of this Issue 2/2017

Virchows Archiv 2/2017 Go to the issue